Initial Testing for Suspected Kidney Disease
The initial test to order for suspected kidney disease should be both a urine albumin-to-creatinine ratio (uACR) and serum creatinine with estimated glomerular filtration rate (eGFR). 1
Rationale for Dual Testing Approach
Urine Albumin-to-Creatinine Ratio (uACR)
- Preferred method for detecting kidney damage as it provides a sensitive marker for chronic kidney disease due to diabetes, glomerular disease, and hypertension 1
- More sensitive than standard dipstick tests, especially at lower levels of proteinuria 1
- Can detect microalbuminuria (30-300 mg/g), which represents early kidney damage before progression to overt proteinuria 2
- Should be performed on a spot urine sample, preferably first morning void 1, 2
Serum Creatinine with eGFR
- Essential for assessing kidney function 1
- Should be calculated using a GFR estimating equation rather than relying on serum creatinine alone 1
- Provides classification of kidney function according to GFR categories (G1-G5) 1
Testing Algorithm
Initial Assessment:
Interpretation of Results:
Confirmation:
Special Considerations
High-Risk Populations
More vigilant screening is recommended for:
- Patients with diabetes 1
- Patients with hypertension 1, 2
- African American individuals 1, 2
- Patients with hepatitis C virus coinfection 1
- Older adults 1
Technical Aspects
- The ratio of albumin to creatinine corrects for variations in urine concentration 1
- uACR is more accurate than total protein-to-creatinine ratio (uPCR) for early detection of kidney disease 2, 3
- Point-of-care testing for uACR can facilitate immediate clinical decision-making 4
Common Pitfalls to Avoid
- Don't rely on standard dipstick alone: Standard dipsticks have lower sensitivity for detecting microalbuminuria 1, 5
- Don't use isolated serum creatinine: Creatinine alone without eGFR calculation is insufficient 1
- Don't ignore borderline results: Values near cutoff points should be confirmed with repeat testing 1
- Don't forget to assess chronicity: CKD requires persistence of abnormalities for >3 months 1
By following this dual testing approach of uACR and eGFR, clinicians can effectively screen for, diagnose, and stage kidney disease, enabling earlier intervention to prevent disease progression and complications.